Asian Phytoceuticals PCLBKK:APCO-R 62 Return-on-Tangible-Equity is 12.42% as of Mar. 2026, which is 2% below its 10-year median of 12.70. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.61. The stock has 4 warning signs investors should review. Among 1,875 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks better than 60.59% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Asian Phytoceuticals PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿70.2 Mil. Asian Phytoceuticals PCL's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ฿565.5 Mil. Therefore, Asian Phytoceuticals PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 12.42%.
The historical rank and industry rank for Asian Phytoceuticals PCL's Return-on-Tangible-Equity or its related term are showing as below:
BKK:APCO-R'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.39 Med: 12.7 Max: 21.63
Current: 10.97
During the past 13 years, Asian Phytoceuticals PCL's highest Return-on-Tangible-Equity was 21.63%. The lowest was 9.39%. And the median was 12.70%.
BKK:APCO-R's Return-on-Tangible-Equity is ranked better than 60.59% of 1875
companies
in the Consumer Packaged Goods industry
Industry Median: 7.72
vs BKK:APCO-R: 10.97
Asian Phytoceuticals PCL (BKK:APCO-R) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Asian Phytoceuticals PCL Return-on-Tangible-Equity Related Terms
Asian Phytoceuticals PCL Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Asian Phytoceuticals PCL's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL Return-on-Tangible-Equity Chart
BKK:APCO-R vs PG, CL, KVUE: Return-on-Tangible-Equity Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 12.42% mean?
Asian Phytoceuticals PCL (BKK:APCO-R) has a Return-on-Tangible-Equity of 12.42% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Asian Phytoceuticals PCL and its competitors. This is near median its historical median of 12.70. Over the past decade, Asian Phytoceuticals PCL's Return-on-Tangible-Equity has ranged from 9.39 to 21.63. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #739 out of 1875 companies in the Consumer Packaged Goods industry, placing it in the top 39.4%.
Is Asian Phytoceuticals PCL's Return-on-Tangible-Equity too high?
Asian Phytoceuticals PCL's current Return-on-Tangible-Equity of 12.42% is near median its 10-year median of 12.70. Over the past 10 years, this metric has ranged from a low of 9.39 to a high of 21.63. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.72. Asian Phytoceuticals PCL's value of 12.42% is 60.9% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #739 out of 1875 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Return-on-Tangible-Equity compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #739 out of 1875 companies for Return-on-Tangible-Equity. This puts Asian Phytoceuticals PCL in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.72. Asian Phytoceuticals PCL's value of 12.42% is 60.9% above this benchmark. Historically, Asian Phytoceuticals PCL's own Return-on-Tangible-Equity has ranged from 9.39 to 21.63 over the past decade. While the company's 10-year median is 12.70 vs. the industry median of 7.72, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.72, based on 1,875 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current Return-on-Tangible-Equity of 12.42% is 60.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current Return-on-Tangible-Equity is 12.42%, which is near median its own 10-year median of 12.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Return-on-Tangible-Equity of 12.42%. The stock's GF Value™ is ฿7.61, compared to a current price of ฿6.27 — trading 17.6% below its estimated fair value. The current Return-on-Tangible-Equity is 12.42%, which is near median its 10-year median of 12.70 and 60.9% above the Consumer Packaged Goods industry median of 7.72. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Return-on-Tangible-Equity is 12.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 17.6% below its estimated GF Value™ of ฿7.61.
Key valuation signals for BKK:APCO-R:
Return-on-Tangible-Equity: 12.42% (near median its 10-year median of 12.70)
GF Value™: ฿7.61 vs. price of ฿6.27 (17.6% below fair value)
Industry Position: 60.9% above the Consumer Packaged Goods median (#739 of 1875)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
